SPRY
ARS Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$8.39
+0.15 ▲ +1.82%
🌙 3월 13일 7:30 PM ET (한국 3/14 08:30)
$8.55
+0.16 ▲ +1.91%
| Index | RUT | P/E | - | EPS (ttm) | -1.74 | Insider Own | 37.43% | Shs Outstand | 0.10B | Perf Week | -7.4% |
| Market Cap | 0.83B | Forward P/E | - | EPS next Y | 59.57% | Insider Trans | -0.5% | Shs Float | 0.06B | Perf Month | -11.68% |
| Enterprise Value | 0.69B | PEG | - | EPS next Q | -0.49 | Inst Own | 69.67% | Short Float | 36.62% | Perf Quarter | -19.64% |
| Income | -0.17B | P/S | 9.88 | EPS this Y | 15.72% | Inst Trans | 4.79% | Short Ratio | 16.06 | Perf Half Y | -17.34% |
| Sales | 0.08B | P/B | 7.29 | EPS next 5Y | - | ROA | -50.47% | Short Interest | 22.75M | Perf YTD | -27.98% |
| Book/sh | 1.15 | P/C | 3.4 | EPS past 3/5Y | -26.04% -12.85% | ROE | -92.33% | 52W High | -55.61% ($18.90) | Perf Year | -29.79% |
| Cash/sh | 2.47 | P/FCF | - | Sales past 3/5Y | 300.09% - | ROIC | -81.33% | 52W Low | 25.98% ($6.66) | Perf 3Y | 3.84% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -2365.06% | Gross Margin | 75.77% | Volatility(W/M) | 7.4% 5.83% | Perf 5Y | -84.89% |
| Dividend TTM | - | EV/Sales | 8.13 | Sales Y/Y TTM | -5.46% | Oper. Margin | -212.92% | ATR (14) | 0.53 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 7.06 | EPS Q/Q | -181.84% | Profit Margin | -203.25% | RSI (14) | 34.88 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 7.28 | Sales Q/Q | -67.56% | SMA20 | -7.04% ($9.03) | Beta | 0.84 | Target Price | $27 |
| Payout | - | Debt/Eq | 0.85 | Earnings | 3000000 | SMA50 | -15.82% ($9.97) | Rel Volume | 0.74 | Prev Close | $8.24 |
| Employees | 158 | LT Debt/Eq | 0.84 | EPS/Sales Surpr. | 4.63% 9.69% | SMA200 | -29.57% ($11.91) | Avg Volume(3M) | 1.42M | Price | $8.39 |
| IPO | 2020/12/4 | Option/Short | Yes/Yes | Trades | 12532 | Volume | 1,041,707 | Change | 1.82% |
뉴스 로딩 중...